CMS ENERGY CORPORATION (CMS) AND TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) RALLY STUCK IN THE CHIMNEY?

Looking at top Wall Street opinions, CMS Energy Corporation (NYSE: CMS) has recently made its way into the research list of BofA/Merrill – signaling that their analyst’s rating adjustment is noteworthy. This stock was upgraded to a rating of Buy in the eyes of BofA/Merrill, whereas its previous rating was Neutral in the eyes of BofA/Merrill, as reported on Thursday, April 11th, 2019. Another heavy-hitting research note was published by Goldman on Thursday January 17th, 2019, with this firm Initiated CMS to an updated rating of Neutral. In the past six months and three months of trading, shares of CMS Energy Corporation (CMS) have moved by 9.21% and 8.05%, respectively. This publicly-traded organization generated gains of 2.03% over the last 5 sessions. Right now, this stock is the subject of 17 analysts’ evaluations, who – on average – have given this company’s shares a Buy rating. Not a Single analyst have given underperform rating or sell rating, and 4 have given a rating of Buy or better. Based on the 17 stock market experts following this company, the average 12-month price target is $56.38. Moreover, individual price targets range between $53.00-$61.00. With its recent move to $56.50, we can see that these firms project this stock will gain by 19.71% in one year.

Spotlight

Spotlight

Related News